1GLOBAL
Kuwait-based low-cost airline Jazeera Airways has partnered with London headquartered Telco 1GLOBAL to become the first airline in the MENA region to launch its own travel eSIM offering. The collaboration will enable Jazeera passengers to communicate cost-effectively and avoid expensive roaming costs when travelling. At the same time, it will serve to strengthen Jazeera Airways´ customer loyalty and satisfaction, while boosting ancillary revenues.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240122511628/en/
Yousef Al Qatami, Chief of Staff at 1GLOBAL. (Source: 1GLOBAL)
Leveraging the power of eSIM
Through the partnership 1GLOBAL will integrate its consumer eSIM technology into Jazeera Airlines' service offering. The process will begin with the implementation of a Jazeera branded QR code and web-based solution, followed by a full-fledged integration into the Jazeera Airways app. The white label solution allows Jazeera to offer eSIM services while maintaining the airlines own look and feel.
Andrew Ward, Vice President Marketing & Customer Experience at Jazeera Airways, says: "We are delighted to be able to offer the 1GLOBAL service to our passengers. We are always looking for ways to reduce travel costs and the 1GLOBAL eSIM offers low call rates for travellers across the Jazeera network."
A benefit for both the airline and its passengers
The roaming solution will be marketed through various communication channels including social media, in-flight magazines, email confirmations and promotional material in airport terminals. The partnership offers benefits for both travellers and Jazeera Airways. By activating the 1GLOBAL roaming eSIM, travellers will be able to stay connected more cost effectively than if they were using their standard roaming plan. They will also have access to high quality 5G & 4G coverage in almost all countries with plenty of flexible tariff options to choose from. Jazeera Airways on the other hand hopes to increase customer loyalty by providing this value-added service. This initiative not only distinguishes Jazeera Airways from its competitors through innovative offerings, but it also aims to increase revenue through ancillary services.
Yousef Al Qatami, Chief of Staff at 1GLOBAL, emphasises: "We are very proud to have supported the Jazeera Airways team in being the first airline in the MENA region to launch an eSIM offering. We are confident in the region's growth trajectory and hope to bring the benefits of eSIM to more local businesses and customers."
About Jazeera Airways
Jazeera Airways operates commercial and cargo flights out of its Jazeera Terminal T5 at Kuwait International Airport. The airline flies to over 64 popular destinations across the Middle East, Central and South Asia, Africa and Europe comprising high-demand business, leisure, religious and weekend destinations.
About 1GLOBAL
Founded in 2022, 1GLOBAL acquired a group of telco assets operational since 2006, including an internationally recognized GSMA-accredited global mobile network. Headquartered in London with our R&D hub in Lisbon, we have grown to over 400 employees across 12 countries and have been granted the status of fully regulated MVNO in 9 of them.
As innovators in eSIM-based GSM mobile services, 1GLOBAL caters to both businesses and individuals with products including mobile call and SMS recording services for businesses, remote SIM provisioning, IOT solutions, Telco-as-a-Service for travel companies, and affordable roaming for everyday consumers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240122511628/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 07:05:00 CET | Press release
L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additio
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release
The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
